Pharmaceutical Cannabinoids: A Company Update
Time: 2:00 pm
day: Day One Track A - afternoon
Details:
- Examine re-purposing of dronabinol for the treatment of obstructive sleep apnea (OSA) and other indications
- Explore completion of two successful Phase 2 clinical trials in OSA
- Develop lipid nanoparticle formulation to overcome current dronabinol limitations
